2p7r
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2p7r.jpg|left|200px]] | [[Image:2p7r.jpg|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2p7r", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_2p7r| PDB=2p7r | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Cyclic pentapeptide which inhibits Hantavirus''' | '''Cyclic pentapeptide which inhibits Hantavirus''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2P7R OCA]. | |
==Reference== | ==Reference== | ||
Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses., Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS, Chem Biol Drug Des. 2007 Mar;69(3):180-90. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17441904 17441904] | Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses., Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS, Chem Biol Drug Des. 2007 Mar;69(3):180-90. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17441904 17441904] | ||
| - | [[Category: Protein complex]] | ||
[[Category: Hall, P R.]] | [[Category: Hall, P R.]] | ||
[[Category: Hjelle, B.]] | [[Category: Hjelle, B.]] | ||
| Line 30: | Line 26: | ||
[[Category: Sillerud, L O.]] | [[Category: Sillerud, L O.]] | ||
[[Category: Ye, C.]] | [[Category: Ye, C.]] | ||
| - | [[Category: | + | [[Category: Biosynthetic protein]] |
| - | [[Category: | + | [[Category: Cyclic pentapeptide]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 12:33:52 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 09:33, 4 May 2008
Cyclic pentapeptide which inhibits Hantavirus
Overview
Hantavirus-induced diseases such as hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome are a global health concern. Hantavirus cardiopulmonary syndrome caused by Sin Nombre virus lacks specific therapy and its high mortality makes Sin Nombre virus a potential bioweapon agent. Sin Nombre virus entry into susceptible cells requires expression of alpha(v)beta(3) integrin. We recently reported the sequence of a cyclic nonapeptide that inhibited Sin Nombre virus entry into Vero E6 cells at a level comparable to ReoPro, a Fab fragment of the anti-beta(3) antibody c7E3. Here, we refine the parental peptide, cyclo-[CPFVKTQLC], using alanine scanning and amino acid deletions, by optimizing for viral inhibition. The IC(50) of the resulting peptide, cyclo-[CPFVC], was 267 microM compared with 263 microM for the parental peptide. The solution structure of cyclo-[CPFVC] was determined by two-dimensional nuclear magnetic resonance spectroscopy, revealing the Phe ring in an extended conformation stacked against the Pro ring and containing a beta-turn encompassing Val-4 through Cys-1. As an initial step in identifying interactions between cyclo-[CPFVC] and its target cellular receptor, the refined peptide structure was docked into the ReoPro binding site of integrin beta(3). This structure will provide the basis for designing more potent peptidomimetic therapeutics to prevent Sin Nombre virus entry and treat hantavirus cardiopulmonary syndrome.
About this Structure
Full crystallographic information is available from OCA.
Reference
Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses., Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS, Chem Biol Drug Des. 2007 Mar;69(3):180-90. PMID:17441904 Page seeded by OCA on Sun May 4 12:33:52 2008
